Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
5.44
-0.11 (-1.98%)
At close: May 15, 2026, 4:00 PM EDT
5.38
-0.06 (-1.10%)
Pre-market: May 18, 2026, 5:11 AM EDT
Inventiva Revenue
In the year 2025, Inventiva had annual revenue of 4.48M EUR, down -51.26%. Inventiva had revenue of 29.00K in the half year ending December 31, 2025, a decrease of -99.81%.
Revenue (ttm)
4.48M EUR
Revenue Growth
-51.26%
P/S Ratio
146.26
Revenue / Employee
58,221 EUR
Employees
77
Market Cap
1.16B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.48M | -4.72M | -51.26% |
| Dec 31, 2024 | 9.20M | -8.28M | -47.37% |
| Dec 31, 2023 | 17.48M | 5.30M | 43.50% |
| Dec 31, 2022 | 12.18M | 7.99M | 190.39% |
| Dec 31, 2021 | 4.19M | 3.82M | 1,027.42% |
| Dec 31, 2020 | 372.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maravai LifeSciences Holdings | 204.73M |
| AbCellera Biologics | 79.21M |
| Septerna | 72.26M |
| Zenas BioPharma | 10.00M |
| Aktis Oncology | 8.28M |
| DBV Technologies | 5.74M |
IVA News
- 5 days ago - Inventiva to Present Abstracts at the EASL Congress 2026 - GlobeNewsWire
- 25 days ago - Inventiva (IVA) Enhances Leadership Team with New Appointments - GuruFocus
- 25 days ago - Inventiva CFO Jean Volatier to switch roles, Axel-Sven Malkomes to succeed - TheFly
- 25 days ago - Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor - GlobeNewsWire
- 4 weeks ago - Three new option listings and one option delisting on April 15th - TheFly
- 5 weeks ago - Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F - GlobeNewsWire
- 6 weeks ago - Inventiva price target lowered to $15 from $17 at Stifel - TheFly
- 6 weeks ago - Inventiva Earnings Call Transcript: Q4 2025 - Transcripts